Suppliers / Zhejiang Taizhou Hisyn Pharmaceutical

Zhejiang Taizhou Hisyn Pharmaceutical

China Updated 9 July 2026

Zhejiang Taizhou Hisyn Pharmaceutical is an API manufacturer based in China. It holds 4 valid CEPs across a filed portfolio of 3 molecules.

0
active US DMFs
4
valid CEPs
2
registered plants
0
filings across 0 regulators

Registered plants

Site FDA FEI
Linhai, China Not on file
Taizhou, China Not on file

What they file, and where

Molecule Regulators Docs
Iohexol EDQM 2
Iopamidol EDQM 2
Iodixanol SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Iodixanol API Iohexol API Iopamidol API

Questions about Zhejiang Taizhou Hisyn Pharmaceutical

Does Zhejiang Taizhou Hisyn Pharmaceutical hold a US DMF or a CEP?
Zhejiang Taizhou Hisyn Pharmaceutical holds 4 valid CEPs. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Where does Zhejiang Taizhou Hisyn Pharmaceutical manufacture?
2 registered sites are on record, in China (Linhai and Taizhou). Every site is listed on this page with the register it came from.
What does Zhejiang Taizhou Hisyn Pharmaceutical make?
3 molecules are on record against Zhejiang Taizhou Hisyn Pharmaceutical, including Iohexol, Iopamidol and Iodixanol. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Zhejiang Taizhou Hisyn Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Suzhou Ryway Biotech shares 3 molecules Zhejiang Starry Pharmaceutical shares 3 molecules Divi's Laboratories shares 2 molecules GE Healthcare shares 2 molecules Zhejiang Haizhou Pharmaceutical shares 2 molecules

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability